Biotech · Public company · Silver Spring, MD, US
UNITED THERAPEUTICS Corp
Ticker UTHR · SEC CIK 0001082554
Track this companyFree. Adds UNITED THERAPEUTICS Corp to your Dealase workspace and tells you when its record changes.
Clinical trials2519 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline14
- Inhaled TreprostinilPhase 3 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled TreprostinilPhase 3 · Progressive Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled treprostinil solutionPhase 3 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- RalinepagPhase 3 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- RalinepagPhase 3 · PAHClinicalTrials.gov · fetched Nov 12, 2026
- treprostinil SMI (treprostinil inhalation spray)Phase 3 · Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Ultrasonic NebulizerPhase 3 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Treprostinil Ultrasonic NebulizerPhase 3 · Progressive Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- 10 GE XenokidneyPhase 2 · ESRD (End-Stage Renal Disease)ClinicalTrials.gov · fetched Nov 12, 2026
- GGTA1 KO ThymokidneyPhase 2 · ESRD (End-Stage Renal Disease)ClinicalTrials.gov · fetched Nov 12, 2026
- Oral treprostinilPulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Parenteral TreprostinilPulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Prospective study assessmentsPulmonary Hypertension Due to Lung Diseases and HypoxiaClinicalTrials.gov · fetched Nov 12, 2026
- Right heart catheterization (RHC)Interstitial Lung DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)PHASE2_PHASE3 · NOT_YET_RECRUITING · started Mar 1, 2027ClinicalTrials.gov NCT07923526 · fetched Nov 12, 2026
- NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + DinutuximabPHASE2 · NOT_YET_RECRUITING · started Dec 31, 2026ClinicalTrials.gov NCT07261241 · fetched Nov 12, 2026
- Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)PHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07923591 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRDPHASE1_PHASE2 · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07224763 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRDPHASE1_PHASE2 · RECRUITING · started Oct 29, 2025ClinicalTrials.gov NCT06878560 · fetched Nov 12, 2026
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With HypoxemiaPHASE2 · RECRUITING · started Sep 29, 2025ClinicalTrials.gov NCT07037836 · fetched Nov 12, 2026
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionNA · RECRUITING · started Jul 23, 2025ClinicalTrials.gov NCT06911632 · fetched Nov 12, 2026
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)RECRUITING · started Jan 23, 2025ClinicalTrials.gov NCT06388421 · fetched Nov 12, 2026
- NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialPHASE2 · RECRUITING · started Dec 16, 2024ClinicalTrials.gov NCT06450041 · fetched Nov 12, 2026
- Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial HypertensionNA · ACTIVE_NOT_RECRUITING · started Jul 29, 2024ClinicalTrials.gov NCT06477640 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)PHASE3 · RECRUITING · started Oct 30, 2023ClinicalTrials.gov NCT05943535 · fetched Nov 12, 2026
- Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionCOMPLETED · started Aug 11, 2023ClinicalTrials.gov NCT05776225 · fetched Nov 12, 2026
- Rapid Administration Pilot for Infusing DinutuximabPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 29, 2022ClinicalTrials.gov NCT05421897 · fetched Nov 12, 2026
- A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionPHASE4 · ACTIVE_NOT_RECRUITING · started Oct 20, 2022ClinicalTrials.gov NCT05203510 · fetched Nov 12, 2026
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseasePHASE3 · ENROLLING_BY_INVITATION · started Sep 6, 2022ClinicalTrials.gov NCT04905693 · fetched Nov 12, 2026
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisPHASE3 · COMPLETED · started Jun 1, 2021ClinicalTrials.gov NCT04708782 · fetched Nov 12, 2026
- Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH SubjectsPHASE3 · TERMINATED · started Jan 20, 2021ClinicalTrials.gov NCT04084678 · fetched Nov 12, 2026
- Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney TransplantationPHASE1_PHASE2 · RECRUITING · started Nov 13, 2020ClinicalTrials.gov NCT04005469 · fetched Nov 12, 2026
- Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary HypertensionPHASE2 · COMPLETED · started Jan 30, 2020ClinicalTrials.gov NCT03814317 · fetched Nov 12, 2026
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · ENROLLING_BY_INVITATION · started Sep 23, 2019ClinicalTrials.gov NCT03683186 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsPHASE3 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03626688 · fetched Nov 12, 2026
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK CellsPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 14, 2019ClinicalTrials.gov NCT02573896 · fetched Nov 12, 2026
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)PHASE3 · TERMINATED · started Dec 21, 2018ClinicalTrials.gov NCT03794583 · fetched Nov 12, 2026
- ADAPT - A Patient Registry of the Real-world Use of Orenitram®ACTIVE_NOT_RECRUITING · started Jul 18, 2017ClinicalTrials.gov NCT03045029 · fetched Nov 12, 2026
- DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support StudyNA · ACTIVE_NOT_RECRUITING · started Jun 1, 2011ClinicalTrials.gov NCT01321073 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 22, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026